12 results
8-K
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
1 Sep 23
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
12:00am
for BRCA1/BRCA2 (Selected Variants). Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted
DEFR14A
ME
23andMe Holding Co - Ordinary Shares
26 Jul 23
Revised proxy
9:14pm
believe that the members of the Board, as a group, have such diversity in terms of backgrounds and experiences, including varied race, ethnicity … , abilities, industry knowledge, experience, gender, race, ethnicity, and veteran and disability status, as well as such other factors considered useful
8-K
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
7 Nov 22
23andMe Reports FY2023 Second Quarter Financial Results
4:06pm
of genetic markers, along with a person’s ethnicity and birth sex. The new reports released in the second quarter were:
○Anxiety report
○Fibromyalgia
8-K
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
8 Aug 22
23andMe Reports FY2023 First Quarter Financial Results
4:14pm
thousands of genetic markers, along with a person’s ethnicity and birth sex. The new reports released in the first quarter were:
Glaucoma report
DEF 14A
gx35s35z8j6
15 Jul 22
Definitive proxy
8:05am
8-K
EX-99.1
runm ely17oglsj6t0o
26 May 22
23andMe Reports FY2022 Fourth Quarter and Full Year Financial Results
4:02pm
8-K
EX-99.1
z1iqzvk6g
10 Feb 22
23andMe Reports FY2022 Third Quarter Financial Results
4:11pm
8-K
EX-99.1
2jng67y
10 Nov 21
Results of Operations and Financial Condition
4:11pm
8-K
EX-99.1
ex2g rkqcxe3
13 Aug 21
23andMe Reports FY2022 First Quarter Financial Results
7:13am
8-K
EX-2.1
08lhl3bk7c0iz36u7q22
4 Feb 21
Entry into a Material Definitive Agreement
8:45am
425
EX-2.1
mlpdpzx4gx01
4 Feb 21
Business combination disclosure
8:43am
- Prev
- 1
- Next